CNADF
Price
$0.06
Change
-$0.00 (-0.00%)
Updated
Apr 10 closing price
Capitalization
4.01M
ZTS
Price
$153.32
Change
+$0.12 (+0.08%)
Updated
Sep 5 closing price
Capitalization
67.95B
52 days until earnings call
Interact to see
Advertisement

CNADF vs ZTS

Header iconCNADF vs ZTS Comparison
Open Charts CNADF vs ZTSBanner chart's image
CANADABIS CAP
Price$0.06
Change-$0.00 (-0.00%)
Volume$6K
Capitalization4.01M
ZOETIS
Price$153.32
Change+$0.12 (+0.08%)
Volume$1.9M
Capitalization67.95B
CNADF vs ZTS Comparison Chart in %
Loading...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNADF vs. ZTS commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNADF is a Hold and ZTS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (CNADF: $0.06 vs. ZTS: $153.32)
Brand notoriety: CNADF: Not notable vs. ZTS: Notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CNADF: 100% vs. ZTS: 62%
Market capitalization -- CNADF: $4.01M vs. ZTS: $67.95B
CNADF [@Pharmaceuticals: Generic] is valued at $4.01M. ZTS’s [@Pharmaceuticals: Generic] market capitalization is $67.95B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNADF’s FA Score shows that 1 FA rating(s) are green whileZTS’s FA Score has 1 green FA rating(s).

  • CNADF’s FA Score: 1 green, 4 red.
  • ZTS’s FA Score: 1 green, 4 red.
According to our system of comparison, both CNADF and ZTS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ZTS’s TA Score shows that 6 TA indicator(s) are bullish.

  • ZTS’s TA Score: 6 bullish, 4 bearish.

Price Growth

CNADF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while ZTS (@Pharmaceuticals: Generic) price change was -1.97% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.08%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +86.48%.

Reported Earning Dates

ZTS is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZTS($67.9B) has a higher market cap than CNADF($4.01M). ZTS has higher P/E ratio than CNADF: ZTS (26.39) vs CNADF (11.57). CNADF YTD gains are higher at: 78.571 vs. ZTS (-4.979). ZTS has higher annual earnings (EBITDA): 4.02B vs. CNADF (1.54M). ZTS has more cash in the bank: 1.44B vs. CNADF (948K). CNADF has less debt than ZTS: CNADF (9.18M) vs ZTS (6.79B). ZTS has higher revenues than CNADF: ZTS (9.39B) vs CNADF (17.2M).
CNADFZTSCNADF / ZTS
Capitalization4.01M67.9B0%
EBITDA1.54M4.02B0%
Gain YTD78.571-4.979-1,578%
P/E Ratio11.5726.3944%
Revenue17.2M9.39B0%
Total Cash948K1.44B0%
Total Debt9.18M6.79B0%
FUNDAMENTALS RATINGS
ZTS: Fundamental Ratings
ZTS
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
PROFIT vs RISK RATING
1..100
97
SMR RATING
1..100
19
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
84
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CNADFZTS
RSI
ODDS (%)
N/A
Bullish Trend 6 days ago
56%
Stochastic
ODDS (%)
N/A
Bullish Trend 4 days ago
65%
Momentum
ODDS (%)
N/A
Bearish Trend 4 days ago
63%
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
54%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
30%
Bearish Trend 4 days ago
58%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
35%
Bullish Trend 4 days ago
57%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
57%
Declines
ODDS (%)
N/A
Bearish Trend 6 days ago
57%
BollingerBands
ODDS (%)
N/A
Bullish Trend 7 days ago
68%
Aroon
ODDS (%)
N/A
Bearish Trend 4 days ago
53%
View a ticker or compare two or three
Interact to see
Advertisement
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IEF96.780.47
+0.49%
iShares 7-10 Year Treasury Bond ETF
DBAW38.340.05
+0.12%
Xtrackers MSCI All World exUS Hdg Eq ETF
TXUE30.000.03
+0.11%
Thornburg International Equity ETF
INCM27.62N/A
N/A
Franklin Income Focus ETF
XJAN35.72-0.01
-0.02%
FT Vest US Eq Enh & Mod Buf ETF-Jan

CNADF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNADF has been loosely correlated with CHSYF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CNADF jumps, then CHSYF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNADF
1D Price
Change %
CNADF100%
N/A
CHSYF - CNADF
38%
Loosely correlated
N/A
ZTS - CNADF
24%
Poorly correlated
+0.08%
CPHI - CNADF
20%
Poorly correlated
+16.32%
ESAIY - CNADF
5%
Poorly correlated
+2.66%
HLNCF - CNADF
4%
Poorly correlated
-0.61%
More

ZTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZTS has been loosely correlated with VTRS. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ZTS jumps, then VTRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTS
1D Price
Change %
ZTS100%
+0.08%
VTRS - ZTS
46%
Loosely correlated
+1.65%
ELAN - ZTS
45%
Loosely correlated
+5.50%
PAHC - ZTS
41%
Loosely correlated
+0.97%
HLN - ZTS
40%
Loosely correlated
-0.41%
AMRX - ZTS
37%
Loosely correlated
+0.73%
More